BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,736,320 | +19.1% | 30,656,000 | +20.6% | 0.02% | +37.5% |
Q2 2023 | $24,963,410 | -9.1% | 25,414,000 | -5.0% | 0.02% | -15.8% |
Q1 2023 | $27,451,121 | +2455.9% | 26,756,000 | +2543.9% | 0.02% | +1800.0% |
Q4 2022 | $1,074,036 | +260.4% | 1,012,000 | +239.6% | 0.00% | – |
Q1 2022 | $298,000 | -79.5% | 298,000 | -78.6% | 0.00% | -100.0% |
Q4 2021 | $1,453,000 | +195.9% | 1,390,000 | +193.2% | 0.00% | – |
Q2 2021 | $491,000 | -8.1% | 474,000 | -10.2% | 0.00% | – |
Q1 2021 | $534,000 | -65.3% | 528,000 | -63.2% | 0.00% | -100.0% |
Q4 2020 | $1,541,000 | -11.7% | 1,436,000 | -13.7% | 0.00% | 0.0% |
Q3 2020 | $1,745,000 | +10164.7% | 1,663,000 | +11778.6% | 0.00% | – |
Q2 2020 | $17,000 | +13.3% | 14,000 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | 0.0% | 14,000 | 0.0% | 0.00% | – |
Q4 2019 | $15,000 | +36.4% | 14,000 | +27.3% | 0.00% | – |
Q3 2019 | $11,000 | -94.2% | 11,000 | -94.1% | 0.00% | – |
Q1 2019 | $191,000 | -72.6% | 187,000 | -73.3% | 0.00% | -100.0% |
Q4 2017 | $697,000 | -65.6% | 700,000 | -65.0% | 0.00% | -50.0% |
Q3 2017 | $2,026,000 | – | 2,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
IRON Financial LLC | 275,000 | $295,000 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |